All results
1 results for brentuximab and combination chemotherapy younger patients newly diagnosed hodgkin
-
Clinical Trials
The addition of targeted immunotherapy will be safe and well tolerated and facilitate the reduction of anthracycline exposure while preserving lymphoma disease…